Marked increases in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non-neoplastic disease

International Journal of Cancer

Volumn 66, Issue 4, 1996, Pages 420-426

  Shuja, Sania ^a   Murnane, Mary Jo ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN L; MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; THYROID DISEASE; THYROID PAPILLARY CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; AMINO ACID SEQUENCE; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; CATHEPSIN B; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; RNA, MESSENGER; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030007677     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960516)66:4<420::AID-IJC2>3.0.CO;2-Y     Document Type: Article

References (28)

1. BARRETT, A.J. and KIRSCHKE, H., Cathepsin B, cathepsin H and cathepsin L. Methods Enzymol, 80, 535-561 (1981).
2. BERG, E., LEFRANC, J.L., CARTOUZOU, G., DE MICCO, C., FRAGU, P. and LISSITZKY, S., Quantification of thyroglobulin messenger RNA by in situ hybridization in differentiated thyroid cancers. Difference between well-differentiated and moderately differentiated histologic types. Cancer, 56, 345-350 (1985).
3. BUCK, M.R., KARUSTIS, D.G., DAY, N.A., HONN, K.V. and SLOANE, B.F., Degradation of extracellular matrix proteins by human cathepsin B from normal and tumor tissues. Biochem. J., 282, 273-278 (1992).
4. CAMPBELL, R.C., Statistics for biologists, Cambridge University Press, New York (1967).
5. CHAUHAN, S.S., GOLDSTEIN, L.J. and GOTTESMAN, M.M., Expression of cathepsin L in human tumors. Cancer Res., 51, 1478-1481 (1991).
6. CHIRGWIN, J.M., PRZYBYLA, A.E., MACDONALD, R.J. and RUTTER, W.J., Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18, 5294-5299 (1979).
7. DUFFY, M.J., The role of proteolytic enzymes in cancer invasion and metastasis. Clin. exp. Metastasis, 10, 145-155 (1992).
8. DUNN, A.D., CRUTCHFIELD, H.E. and DUNN, J.T., Thyroglobulin processing by thyroidal proteases; major sites of cleavage by cathepsins B, D, and L. J. biol. Chem., 266, 20198-20204 (1991a).
9. DUNN, A.D., CRUTCHFIELD, H.E. and DUNN, J.T., Proteolytic processing of thyroglobulin by extracts of thyroid lysosomes. Endocrinology, 128, 3073-3080 (1991b).
10. DUNN, A.D. and DUNN, J.T., Cysteine proteinases from human thyroids and their actions on thyroglobulin. Endocrinology, 123, 1089-1097 (1988).
11. KHAIRALLAH, E.A., BOND, J.S. and BIRD, J.W.C. (eds.), Intracellular protein catabolism, A.R. Liss, New York (1985).
12. KOMINAMI, E. and TSUKAHARA, T., Distribution of cathepsin B and H in rat tissues and peripheral blood cells. J. Biochem., 98, 87-93 (1985).
13. LAH, T.T., BUCK, M.R., HONN, K.V., CRISSMAN, J.D., RAO, N.C., LIOTTA, L.A. and SLOANE, B.F., Degradation of laminin by human tumor cathepsin B. Clin. exp. Metastasis, 7, 461-468 (1989).
14. LOWRY, O., ROSEBROUGH, N.J., FARR, A.L. and RANDALL, R.J., Protein measurement with the folin phenol reagent. J. biol. Chem., 193, 265-275 (1951).
15. MACGREGOR, R.R., HAMILTON, J.W., SHOFSTALL, R.E. and COHN, D.V., Isolation and characterization of porcine parathyroid cathepsin B.J. biol. Chem., 254, 4423-4427 (1979).
16. MACIEWICZ, R.A., WARDALE, R.J., ETHERINGTON, D.J. and PARASKEVA, C., Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines. Int. J. Cancer, 43, 478-486 (1989).
17. MOIN, K., ROZHIN, J., MCKERNAN, T.B., SANDERS, V.J., FONG, D., HONN, K.V. and SLOANE, B.F., Enhanced levels of cathepsin B mRNA in murine tumors. FEBS Lett., 244, 61-64 (1989).
18. MURNANE, M.J., SHEAHAN, K., OZDEMIRLI, M. and SHUJA, S., Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma. Cancer Res., 51, 1137-1142 (1991).
19. OHTA, K., ENDO, T. and ONAYA, T., The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxidase in neoplastic human thyroid tissues. Biochem. biophys. Res. Comm., 174, 1148-1153 (1991).
20. PHILLIPS, I.D., BLACK, E.G., SHEPPARD, M.C. and DOCHERTY, K., Thyrotrophin, forskolin and ionomycin increase cathepsin B mRNA concentrations in rat thyroid cells in culture. J. mol. Endocrinol., 2, 207-212 (1989).
21. QIAN, F., FRANKFATER, A., MILLER, R.V., CHAN, S.J. and STEINER, D.F., Molecular cloning of rat precursor cathepsin H and the expression of five lysosomal cathepsins in normal tissues and in a rat carcinosarcoma. Int. J. Biochem., 22, 1457-1464 (1990).
22. RINNE, A., JARVINEN, M., KIRSCHKE, H., WIEDERANDERS, B. and HOPSU-HAVU, V.K., Demonstration of cathepsin H and L in rat tissues. Biomed. Biochim. Acta, 45, 1465-1476 (1986).
23. SHEAHAN, K.S., SHUJA, S. and MURNANE, M.J., Cysteine protease activities and tumor development in human colorectal carcinoma. Cancer Res., 49, 3809-3814 (1989).
24. SHUJA, S., SHEAHAN, K. and MURNANE, M.J., Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas. Int. J. Cancer, 49, 341-346 (1991).
25. SLOANE, B.F., Cathepsin B and cystatins: evidence for a role in cancer progression. Semin. Cancer Biol., 1, 137-152 (1990).
26. STANLEY, J.G., Endocrine system. In: D.R. Bernier, P.E. Christian and J.K. LANGAN (eds.), Nuclear medicine technology and techniques (3rd ed.), pp. 227-238, Mosby, New York (1994).
27. SUZUKI, M. and HIWASA, T. (eds). Proteases involved in cancer, Monduzzi Editore, Bologna (1995).
28. UCHIYAMA, Y., WATANABE, T., WATANABE, M., ISHII, Y., MATSUBA, H., WAGURI, S. and KOMINAMI, E., Immunocytochemical localization of cathepsins B, H, L and T4 in follicular cells of rat thyroid gland. J. Histochem. Cytochem., 37, 691-696 (1989).